Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Journal of Medical Sciences|November 6, 2023
Use of metagenomic next-generation sequencing for diagnosis of peritonitis in end-stage liver diseaseTaiyu He, Ning Luo, Juan Kang, et al.International Journal of Environmental Research and Public Health|November 11, 2022
Impact of Physical Activity on COVID-19Jia Yang, Xiang Li, Taiyu He, et al.Frontiers in Public Health|January 31, 2022
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER DatabaseTaiyu He, Tianyao Chen, Xiaozhu Liu, et al.Journal of Clinical Medicine|March 14, 2026
Diabetes Impairs the Virological Response in Patients with Chronic Hepatitis B: Glycemic Control as a Key Modifiable Risk FactorAoyi Li, Yan Han, Guanglin Xiao, et al.Immunity, Inflammation and Disease|January 27, 2023
Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infectionTaiyu He, Ning Ling, Gaoli Zhang, et al.Frontiers in Endocrinology|August 14, 2023
Local tumor destruction and liver resection increase overall survival in intermediate/advanced hepatocellular carcinoma patients: evidence from a population-based studyYang Zhang, Yi Zhang, Taiyu He, et al.Frontiers in Cellular and Infection Microbiology|June 5, 2026
Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAgChaojing Wen, Taiyu He, Guanhua Zha, et al.International Journal of Public Health|December 6, 2024
Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-AnalysisGuanglin Xiao, Taiyu He, Biqiong Zhang, et al.Journal of Clinical and Translational Hepatology|January 1, 2024
Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with CirrhosisQian Zhu, Lu Wang, Xiaoxiao Hu, et al.Journal of Clinical and Translational Hepatology|February 12, 2024
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver DiseasesZhiwei Chen, Yuting Wang, Taiyu He, et al.Pageof 2